R5459-RT-1956 Original

Nephrology
Robert Redfield III
R5459-RT-1956 Original: A Noninterventional Extension Study for Patients Treated in Study R5459-rt-1944 With Regn5459 or Regn5458 (Bcma × Cd3 Bispecific Antibodies) Who Receive a Kidney Transplant
Kidney - Nephrology

Study Description

Eligibility

  1. Received at least 1 dose of treatment with REGN5459 or REGN5458 in study R5459-RT-1944
  2. Received, or scheduled to receive after acceptable crossmatching, a kidney transplant while enrolled in study R5459-RT-1944
  3. Willing and able to comply with clinic visits and study-related procedures
  4. Provide informed consent signed by study patient or legally acceptable representative
  1. There are no exclusion criteria for this study.

Note: Other protocol defined Inclusion/Exclusion criteria may app

A female nurse attentively holds a tablet, ready to assist with patient care and medical information.

Interested in Participating in this Trial?

Thank you for your interest with our team.

One of our specialists will be in contact with you soon.